0001209191-16-145584.txt : 20161011
0001209191-16-145584.hdr.sgml : 20161011
20161011163746
ACCESSION NUMBER: 0001209191-16-145584
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161007
FILED AS OF DATE: 20161011
DATE AS OF CHANGE: 20161011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huber Reid M
CENTRAL INDEX KEY: 0001607052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 161931467
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN
STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-07
0
0000879169
INCYTE CORP
INCY
0001607052
Huber Reid M
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, Chief Scientific Officer
Common Stock
2016-10-07
4
M
0
11709
18.32
A
78310
D
Common Stock
2016-10-07
4
S
0
11709
96.40
D
66601
D
Non-Qualified Stock Option (right to buy)
18.32
2016-10-07
4
M
0
11709
0.00
D
2020-02-08
Common Stock
11709
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Represents weighted average sale price. Actual sale prices ranged from $95.24 - $97.00
Includes an aggregate of 27,496 shares of common stock issuable to previously reported restricted stock units that have not vested.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Eric H. Siegel, Attorney-In-Fact
2016-10-11